复杂主动脉腔内修复中治疗性脑脊液引流对脊髓缺血的临床结局
单中心回顾性队列研究纳入17例使用t-Branch器械行开窗/分支腔内修复的Crawford I-V型胸腹主动脉瘤或肾旁腹主动脉瘤患者。5例(29%)发生脊髓缺血并接受治疗性脑脊液引流,中位Tarlov评分从1分改善至出院时4分,院内死亡12%(2/17)。
要点
- 治疗性脑脊液引流在结构化多学科方案下与神经功能改善相关。
- 多数患者出院时仍残留轻至中度运动缺损。
- 症状触发的方案化脑脊液引流可作为可行的挽救策略。
核心结论
- 治疗性脑脊液引流在结构化多学科方案下与脊髓缺血患者神经功能改善相关,但多数患者出院时仍残留轻至中度缺损。
- 作者认为症状触发、基于方案的脑脊液引流策略可作为可行的挽救策略,但需谨慎解读并等待更大规模多中心研究验证。
研究设计与样本
- 单中心回顾性观察性队列研究,2017年1月至2022年1月在一家三级学术医疗中心开展。
- 纳入17例使用Zenith t-Branch器械行完全腔内修复的Crawford I-V型胸腹主动脉瘤或肾旁腹主动脉瘤患者。
- 遵循标准化多学科脊髓保护方案,确诊脊髓缺血后1小时内启动治疗性脑脊液引流。
主要发现
- 技术成功率为59/62例计划目标血管(95%)。
- 5例患者(29%)发生脊髓缺血,均接受治疗性脑脊液引流。
- 确诊脊髓缺血至置管的中位时间为46分钟(范围31-51)。
- 中位Tarlov评分从脊髓缺血发生时的1分(范围0-2)改善至出院时的4分(范围3-5)。
- 1例患者实现完全神经功能恢复(Tarlov 5分),4例残留轻至中度运动缺损。
关键数值与推荐
- 主要结局为治疗性脑脊液引流后神经功能恢复,采用改良Tarlov量表评估。
- 次要结局包括技术成功、院内死亡率和随访期间动脉瘤囊回缩。
- 治疗性脑脊液引流在确诊脊髓缺血后1小时内启动。
临床怎么用
- 在结构化多学科脊髓保护方案下,对F/B-EVAR术后发生脊髓缺血的患者可考虑症状触发的治疗性脑脊液引流作为挽救策略。
- 应认识到多数患者出院时仍残留轻至中度运动缺损,需谨慎评估获益与局限。
局限性
- 本研究为单中心回顾性观察性研究,样本量小(17例),仅5例发生脊髓缺血。
- 观察性设计限制因果推断,结论需经更大规模多中心研究验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Spinal cord ischemia (SCI) remains a major concern following thoracoabdominal aortic aneurysm (TAAA) repair, even with advances in endovascular techniques. The clinical efficacy of selective therapeutic cerebrospinal fluid drainage (CSFD) over routine prophylactic strategies for managing postprocedural SCI remains to be fully elucidated. This study evaluated outcomes of fenestrated and branched endovascular aortic repair (F/B-EVAR) using the Zenith t-Branch device and assessed the neurological outcomes of therapeutic CSFD in patients who developed postoperative SCI. MATERIALS AND METHODS: A single-center retrospective observational cohort study was conducted at a tertiary academic medical center between January 2017 and January 2022, including 17 patients who underwent total endovascular repair for Crawford type I-V TAAA or pararenal AAA using the t-Branch device. The primary outcome was neurological recovery following therapeutic CSFD, assessed using the modified Tarlov scale. Secondary outcomes included technical success, in-hospital mortality, and aneurysm sac regression during follow-up. A standardized, multidisciplinary spinal cord protection protocol was followed, and therapeutic CSFD was initiated within 1 hour of confirmed SCI. RESULTS: Technical success was achieved in 59 of 62 planned target vessels (95%). Five patients (29%) developed SCI, all of whom underwent therapeutic CSFD. Median time from confirmed SCI to drain placement was 46 minutes (range 31-51). Median Tarlov scale score improved from 1 (range 0-2) at SCI onset to 4 (range 3-5) at discharge. One patient achieved complete neurological recovery (Tarlov 5); 4 had residual mild-to-moderate motor deficits. In-hospital mortality was 12% (2/17), both from nonaortic causes. During a median follow-up of 13 months (IQR 9-24), all surviving patients demonstrated aneurysm sac regression, and no secondary interventions were required. CONCLUSIONS: Therapeutic CSFD, implemented within a structured multidisciplinary protocol, was associated with neurological improvement in our small cohort, although the majority of patients retained residual mild-to-moderate deficits at discharge. These findings support a symptom-triggered, protocol-based CSFD strategy as a feasible rescue strategy that warrants cautious interpretation given its observational nature, and further validation through larger multicenter studies is required.
引用
- Liu MY, Chi NH, Yu HY, et al. Clinical Outcomes with Therapeutic Cerebrospinal Fluid Drainage for Spinal Cord Ischemia in Complex Endovascular Aortic Repair Using Fenestrated and Branched Stent-Grafts. J Endovasc Ther. 2026. PMID: 42635018. doi:10.1177/15266028261479536
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。